nodes	percent_of_prediction	percent_of_DWPC	metapath
Gonadorelin—Redness—Niacin—atherosclerosis	0.022	0.0386	CcSEcCtD
Gonadorelin—GNRHR—Peptide GPCRs—CX3CR1—atherosclerosis	0.0175	0.0406	CbGpPWpGaD
Gonadorelin—Breast pain—Niacin—atherosclerosis	0.017	0.0298	CcSEcCtD
Gonadorelin—GNRHR—G alpha (q) signalling events—HRH1—atherosclerosis	0.0135	0.0313	CbGpPWpGaD
Gonadorelin—Breast disorder—Rosuvastatin—atherosclerosis	0.0134	0.0235	CcSEcCtD
Gonadorelin—Swelling—Simvastatin—atherosclerosis	0.0133	0.0233	CcSEcCtD
Gonadorelin—GNRHR—Peptide GPCRs—EDNRA—atherosclerosis	0.0126	0.0294	CbGpPWpGaD
Gonadorelin—GNRHR—Peptide GPCRs—CCR2—atherosclerosis	0.0126	0.0294	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HRH1—atherosclerosis	0.012	0.028	CbGpPWpGaD
Gonadorelin—Breast disorder—Ezetimibe—atherosclerosis	0.0111	0.0195	CcSEcCtD
Gonadorelin—GNRHR—Peptide GPCRs—AGTR1—atherosclerosis	0.0107	0.025	CbGpPWpGaD
Gonadorelin—GNRHR—GPCRs, Other—EDNRA—atherosclerosis	0.0107	0.0249	CbGpPWpGaD
Gonadorelin—Abdominal discomfort—Lovastatin—atherosclerosis	0.0104	0.0182	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.00988	0.0173	CcSEcCtD
Gonadorelin—Abdominal discomfort—Simvastatin—atherosclerosis	0.00972	0.017	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00943	0.0165	CcSEcCtD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—HRH1—atherosclerosis	0.00892	0.0208	CbGpPWpGaD
Gonadorelin—Flatulence—Rosuvastatin—atherosclerosis	0.00879	0.0154	CcSEcCtD
Gonadorelin—GNRHR—G alpha (q) signalling events—UTS2—atherosclerosis	0.00868	0.0202	CbGpPWpGaD
Gonadorelin—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00852	0.0149	CcSEcCtD
Gonadorelin—GNRHR—G alpha (q) signalling events—CASR—atherosclerosis	0.00832	0.0194	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—UTS2—atherosclerosis	0.00776	0.0181	CbGpPWpGaD
Gonadorelin—Angiopathy—Ezetimibe—atherosclerosis	0.00772	0.0135	CcSEcCtD
Gonadorelin—Immune system disorder—Ezetimibe—atherosclerosis	0.00769	0.0135	CcSEcCtD
Gonadorelin—Flatulence—Lovastatin—atherosclerosis	0.00745	0.0131	CcSEcCtD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—CASR—atherosclerosis	0.00744	0.0173	CbGpPWpGaD
Gonadorelin—Erythema—Ezetimibe—atherosclerosis	0.00741	0.013	CcSEcCtD
Gonadorelin—Flatulence—Ezetimibe—atherosclerosis	0.0073	0.0128	CcSEcCtD
Gonadorelin—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00714	0.0125	CcSEcCtD
Gonadorelin—Erythema—Simvastatin—atherosclerosis	0.00707	0.0124	CcSEcCtD
Gonadorelin—Flatulence—Simvastatin—atherosclerosis	0.00696	0.0122	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—HRH1—atherosclerosis	0.00679	0.0158	CbGpPWpGaD
Gonadorelin—Angiopathy—Niacin—atherosclerosis	0.00676	0.0119	CcSEcCtD
Gonadorelin—Erythema—Niacin—atherosclerosis	0.00649	0.0114	CcSEcCtD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL4—atherosclerosis	0.00645	0.015	CbGpPWpGaD
Gonadorelin—Flatulence—Niacin—atherosclerosis	0.00639	0.0112	CcSEcCtD
Gonadorelin—Flatulence—Pravastatin—atherosclerosis	0.0063	0.011	CcSEcCtD
Gonadorelin—Constipation—Rosuvastatin—atherosclerosis	0.00622	0.0109	CcSEcCtD
Gonadorelin—Pain—Rosuvastatin—atherosclerosis	0.00622	0.0109	CcSEcCtD
Gonadorelin—Anaphylactic shock—Lovastatin—atherosclerosis	0.00617	0.0108	CcSEcCtD
Gonadorelin—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00605	0.0106	CcSEcCtD
Gonadorelin—GNRHR—G alpha (q) signalling events—EDNRA—atherosclerosis	0.00601	0.014	CbGpPWpGaD
Gonadorelin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00595	0.0104	CcSEcCtD
Gonadorelin—Nervous system disorder—Ezetimibe—atherosclerosis	0.00593	0.0104	CcSEcCtD
Gonadorelin—GNRHR—G alpha (q) signalling events—GHRL—atherosclerosis	0.00586	0.0136	CbGpPWpGaD
Gonadorelin—Anaphylactic shock—Simvastatin—atherosclerosis	0.00577	0.0101	CcSEcCtD
Gonadorelin—Abdominal pain—Rosuvastatin—atherosclerosis	0.00575	0.0101	CcSEcCtD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—UTS2—atherosclerosis	0.00575	0.0134	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CX3CR1—atherosclerosis	0.00551	0.0128	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CX3CL1—atherosclerosis	0.0054	0.0126	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—atherosclerosis	0.00538	0.0125	CbGpPWpGaD
Gonadorelin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00536	0.0094	CcSEcCtD
Gonadorelin—Fatigue—Lovastatin—atherosclerosis	0.00532	0.00932	CcSEcCtD
Gonadorelin—Anaphylactic shock—Niacin—atherosclerosis	0.0053	0.00929	CcSEcCtD
Gonadorelin—Constipation—Lovastatin—atherosclerosis	0.00527	0.00925	CcSEcCtD
Gonadorelin—Pain—Lovastatin—atherosclerosis	0.00527	0.00925	CcSEcCtD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—atherosclerosis	0.00524	0.0122	CbGpPWpGaD
Gonadorelin—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00522	0.00915	CcSEcCtD
Gonadorelin—Asthenia—Rosuvastatin—atherosclerosis	0.00522	0.00915	CcSEcCtD
Gonadorelin—Anaphylactic shock—Pravastatin—atherosclerosis	0.00521	0.00914	CcSEcCtD
Gonadorelin—Fatigue—Ezetimibe—atherosclerosis	0.00521	0.00914	CcSEcCtD
Gonadorelin—Shock—Niacin—atherosclerosis	0.00521	0.00914	CcSEcCtD
Gonadorelin—Constipation—Ezetimibe—atherosclerosis	0.00517	0.00907	CcSEcCtD
Gonadorelin—Pain—Ezetimibe—atherosclerosis	0.00517	0.00907	CcSEcCtD
Gonadorelin—Pruritus—Rosuvastatin—atherosclerosis	0.00515	0.00903	CcSEcCtD
Gonadorelin—GNRHR—G alpha (q) signalling events—KNG1—atherosclerosis	0.00514	0.012	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CNR2—atherosclerosis	0.00512	0.0119	CbGpPWpGaD
Gonadorelin—GNRHR—G alpha (q) signalling events—AGTR1—atherosclerosis	0.00511	0.0119	CbGpPWpGaD
Gonadorelin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00504	0.00884	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00498	0.00873	CcSEcCtD
Gonadorelin—Diarrhoea—Rosuvastatin—atherosclerosis	0.00498	0.00873	CcSEcCtD
Gonadorelin—Fatigue—Simvastatin—atherosclerosis	0.00497	0.00872	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00495	0.00867	CcSEcCtD
Gonadorelin—Constipation—Simvastatin—atherosclerosis	0.00493	0.00865	CcSEcCtD
Gonadorelin—Pain—Simvastatin—atherosclerosis	0.00493	0.00865	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—CCL4—atherosclerosis	0.00491	0.0114	CbGpPWpGaD
Gonadorelin—Abdominal pain—Lovastatin—atherosclerosis	0.00487	0.00855	CcSEcCtD
Gonadorelin—Abdominal pain—Ezetimibe—atherosclerosis	0.00478	0.00838	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00472	0.00827	CcSEcCtD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—atherosclerosis	0.0046	0.0107	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—atherosclerosis	0.00457	0.0106	CbGpPWpGaD
Gonadorelin—Gastrointestinal disorder—Niacin—atherosclerosis	0.00457	0.00802	CcSEcCtD
Gonadorelin—Abdominal pain—Simvastatin—atherosclerosis	0.00456	0.00799	CcSEcCtD
Gonadorelin—Headache—Rosuvastatin—atherosclerosis	0.00456	0.00799	CcSEcCtD
Gonadorelin—Hypersensitivity—Lovastatin—atherosclerosis	0.00454	0.00797	CcSEcCtD
Gonadorelin—Pain—Niacin—atherosclerosis	0.00453	0.00794	CcSEcCtD
Gonadorelin—Fatigue—Pravastatin—atherosclerosis	0.0045	0.00788	CcSEcCtD
Gonadorelin—Pain—Pravastatin—atherosclerosis	0.00446	0.00782	CcSEcCtD
Gonadorelin—Constipation—Pravastatin—atherosclerosis	0.00446	0.00782	CcSEcCtD
Gonadorelin—Hypersensitivity—Ezetimibe—atherosclerosis	0.00446	0.00781	CcSEcCtD
Gonadorelin—Asthenia—Lovastatin—atherosclerosis	0.00442	0.00776	CcSEcCtD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL3—atherosclerosis	0.0044	0.0102	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—UTS2—atherosclerosis	0.00438	0.0102	CbGpPWpGaD
Gonadorelin—Pruritus—Lovastatin—atherosclerosis	0.00436	0.00765	CcSEcCtD
Gonadorelin—Asthenia—Ezetimibe—atherosclerosis	0.00434	0.00761	CcSEcCtD
Gonadorelin—GNRHR—G alpha (q) signalling events—EDN1—atherosclerosis	0.00433	0.0101	CbGpPWpGaD
Gonadorelin—Gastrointestinal pain—Niacin—atherosclerosis	0.00433	0.00759	CcSEcCtD
Gonadorelin—Nausea—Rosuvastatin—atherosclerosis	0.00432	0.00758	CcSEcCtD
Gonadorelin—Pruritus—Ezetimibe—atherosclerosis	0.00428	0.0075	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00426	0.00748	CcSEcCtD
Gonadorelin—Hypersensitivity—Simvastatin—atherosclerosis	0.00425	0.00745	CcSEcCtD
Gonadorelin—Diarrhoea—Lovastatin—atherosclerosis	0.00422	0.0074	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—CX3CR1—atherosclerosis	0.00419	0.00976	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—CASR—atherosclerosis	0.00419	0.00976	CbGpPWpGaD
Gonadorelin—Abdominal pain—Niacin—atherosclerosis	0.00419	0.00734	CcSEcCtD
Gonadorelin—Asthenia—Simvastatin—atherosclerosis	0.00414	0.00726	CcSEcCtD
Gonadorelin—Diarrhoea—Ezetimibe—atherosclerosis	0.00414	0.00726	CcSEcCtD
Gonadorelin—Abdominal pain—Pravastatin—atherosclerosis	0.00412	0.00723	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—CX3CL1—atherosclerosis	0.00411	0.00957	CbGpPWpGaD
Gonadorelin—Pruritus—Simvastatin—atherosclerosis	0.00408	0.00715	CcSEcCtD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—atherosclerosis	0.00408	0.00949	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.00398	0.00927	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.00398	0.00927	CbGpPWpGaD
Gonadorelin—Diarrhoea—Simvastatin—atherosclerosis	0.00395	0.00692	CcSEcCtD
Gonadorelin—Vomiting—Lovastatin—atherosclerosis	0.00392	0.00687	CcSEcCtD
Gonadorelin—Hypersensitivity—Niacin—atherosclerosis	0.0039	0.00684	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—CNR2—atherosclerosis	0.0039	0.00908	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.00388	0.00903	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—atherosclerosis	0.00388	0.00902	CbGpPWpGaD
Gonadorelin—Headache—Lovastatin—atherosclerosis	0.00386	0.00677	CcSEcCtD
Gonadorelin—Vomiting—Ezetimibe—atherosclerosis	0.00385	0.00674	CcSEcCtD
Gonadorelin—Hypersensitivity—Pravastatin—atherosclerosis	0.00384	0.00674	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—HRH1—atherosclerosis	0.00384	0.00893	CbGpPWpGaD
Gonadorelin—Asthenia—Niacin—atherosclerosis	0.0038	0.00666	CcSEcCtD
Gonadorelin—Headache—Ezetimibe—atherosclerosis	0.00379	0.00664	CcSEcCtD
Gonadorelin—Pruritus—Niacin—atherosclerosis	0.00375	0.00657	CcSEcCtD
Gonadorelin—Asthenia—Pravastatin—atherosclerosis	0.00374	0.00656	CcSEcCtD
Gonadorelin—Pruritus—Pravastatin—atherosclerosis	0.00369	0.00647	CcSEcCtD
Gonadorelin—Vomiting—Simvastatin—atherosclerosis	0.00367	0.00643	CcSEcCtD
Gonadorelin—Nausea—Lovastatin—atherosclerosis	0.00366	0.00642	CcSEcCtD
Gonadorelin—Diarrhoea—Niacin—atherosclerosis	0.00362	0.00635	CcSEcCtD
Gonadorelin—Headache—Simvastatin—atherosclerosis	0.00361	0.00634	CcSEcCtD
Gonadorelin—GNRHR—G alpha (q) signalling events—AGT—atherosclerosis	0.0036	0.00837	CbGpPWpGaD
Gonadorelin—Nausea—Ezetimibe—atherosclerosis	0.00359	0.0063	CcSEcCtD
Gonadorelin—Diarrhoea—Pravastatin—atherosclerosis	0.00357	0.00626	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—HRH1—atherosclerosis	0.00348	0.00811	CbGpPWpGaD
Gonadorelin—Nausea—Simvastatin—atherosclerosis	0.00343	0.00601	CcSEcCtD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.00341	0.00793	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	0.00339	0.00788	CbGpPWpGaD
Gonadorelin—Vomiting—Niacin—atherosclerosis	0.00337	0.0059	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—CCL3—atherosclerosis	0.00335	0.0078	CbGpPWpGaD
Gonadorelin—GNRHR—G alpha (q) signalling events—F2—atherosclerosis	0.00332	0.00774	CbGpPWpGaD
Gonadorelin—Headache—Niacin—atherosclerosis	0.00332	0.00582	CcSEcCtD
Gonadorelin—Vomiting—Pravastatin—atherosclerosis	0.00332	0.00581	CcSEcCtD
Gonadorelin—Headache—Pravastatin—atherosclerosis	0.00327	0.00573	CcSEcCtD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—atherosclerosis	0.00322	0.00749	CbGpPWpGaD
Gonadorelin—Nausea—Niacin—atherosclerosis	0.00315	0.00552	CcSEcCtD
Gonadorelin—Nausea—Pravastatin—atherosclerosis	0.0031	0.00543	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—EDNRA—atherosclerosis	0.00303	0.00706	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—CCR2—atherosclerosis	0.00303	0.00706	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—F2—atherosclerosis	0.00297	0.00692	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—GHRL—atherosclerosis	0.00296	0.00688	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.00287	0.00668	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.00285	0.00663	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—KNG1—atherosclerosis	0.00259	0.00604	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—AGTR1—atherosclerosis	0.00258	0.006	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CCL4—atherosclerosis	0.00252	0.00586	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—UTS2—atherosclerosis	0.00247	0.00575	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.00238	0.00555	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CASR—atherosclerosis	0.00237	0.00552	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—UTS2—atherosclerosis	0.00225	0.00523	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CNR2—atherosclerosis	0.0022	0.00513	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.0022	0.00512	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—EDN1—atherosclerosis	0.00219	0.00509	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—CCL5—atherosclerosis	0.00217	0.00505	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CASR—atherosclerosis	0.00215	0.00501	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CX3CR1—atherosclerosis	0.00215	0.00501	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CX3CL1—atherosclerosis	0.00211	0.00491	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—HRH1—atherosclerosis	0.00206	0.00479	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CNR2—atherosclerosis	0.002	0.00466	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.00196	0.00457	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—AGT—atherosclerosis	0.00181	0.00422	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CCL3—atherosclerosis	0.00172	0.00401	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CCR2—atherosclerosis	0.00171	0.00399	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—EDNRA—atherosclerosis	0.00171	0.00399	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—F2—atherosclerosis	0.00168	0.0039	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—GHRL—atherosclerosis	0.00167	0.00389	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—APOA4—atherosclerosis	0.00162	0.00376	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.00161	0.00375	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CCR2—atherosclerosis	0.00156	0.00362	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—EDNRA—atherosclerosis	0.00156	0.00362	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.00155	0.00361	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—GHRL—atherosclerosis	0.00152	0.00353	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—CCL2—atherosclerosis	0.00149	0.00348	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCL4—atherosclerosis	0.00149	0.00346	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—KNG1—atherosclerosis	0.00147	0.00341	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—AGTR1—atherosclerosis	0.00146	0.00339	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—APOA2—atherosclerosis	0.00139	0.00324	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—KNG1—atherosclerosis	0.00133	0.0031	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—UTS2—atherosclerosis	0.00133	0.00309	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—AGTR1—atherosclerosis	0.00132	0.00308	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CX3CR1—atherosclerosis	0.00127	0.00296	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CASR—atherosclerosis	0.00127	0.00296	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CX3CL1—atherosclerosis	0.00125	0.0029	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—EDN1—atherosclerosis	0.00124	0.00288	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CCL5—atherosclerosis	0.00123	0.00285	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CNR2—atherosclerosis	0.00118	0.00275	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—CXCL8—atherosclerosis	0.00118	0.00275	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—MMP3—atherosclerosis	0.00118	0.00275	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.00118	0.00274	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PRKCG—atherosclerosis	0.00117	0.00271	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—EDN1—atherosclerosis	0.00112	0.00261	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CCL5—atherosclerosis	0.00111	0.00259	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PRKCG—atherosclerosis	0.00106	0.00246	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—VWF—atherosclerosis	0.00105	0.00245	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—APOC3—atherosclerosis	0.00105	0.00244	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—LDLR—atherosclerosis	0.00104	0.00242	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—AGT—atherosclerosis	0.00103	0.00239	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCL3—atherosclerosis	0.00102	0.00237	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NCF1—atherosclerosis	0.000974	0.00227	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—F2—atherosclerosis	0.000948	0.00221	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—AGT—atherosclerosis	0.000931	0.00217	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCR2—atherosclerosis	0.000919	0.00214	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—EDNRA—atherosclerosis	0.000919	0.00214	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CYBA—atherosclerosis	0.000915	0.00213	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000907	0.00211	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PLAT—atherosclerosis	0.000896	0.00209	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PARP1—atherosclerosis	0.000896	0.00209	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GHRL—atherosclerosis	0.000896	0.00209	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—F2—atherosclerosis	0.00086	0.002	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PIK3CG—atherosclerosis	0.000823	0.00192	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—KNG1—atherosclerosis	0.000786	0.00183	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—AGTR1—atherosclerosis	0.000782	0.00182	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CCL2—atherosclerosis	0.000767	0.00178	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PLG—atherosclerosis	0.000762	0.00177	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—SOCS3—atherosclerosis	0.000721	0.00168	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MMP3—atherosclerosis	0.000697	0.00162	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IGF2—atherosclerosis	0.000694	0.00161	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—APOB—atherosclerosis	0.000673	0.00157	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CXCL8—atherosclerosis	0.000668	0.00155	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—EDN1—atherosclerosis	0.000663	0.00154	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCL5—atherosclerosis	0.000658	0.00153	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—LPL—atherosclerosis	0.000643	0.0015	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PRKCG—atherosclerosis	0.000625	0.00146	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—SPP1—atherosclerosis	0.000609	0.00142	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CXCL8—atherosclerosis	0.000606	0.00141	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PDGFB—atherosclerosis	0.000564	0.00131	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—AGT—atherosclerosis	0.00055	0.00128	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—LEP—atherosclerosis	0.000539	0.00125	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—APOE—atherosclerosis	0.000539	0.00125	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CAV1—atherosclerosis	0.000534	0.00124	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—APOA1—atherosclerosis	0.000533	0.00124	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ESR1—atherosclerosis	0.000515	0.0012	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—F2—atherosclerosis	0.000508	0.00118	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PIK3CG—atherosclerosis	0.000486	0.00113	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—MAPK3—atherosclerosis	0.000466	0.00108	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—INS—atherosclerosis	0.00046	0.00107	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCL2—atherosclerosis	0.000453	0.00105	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IGF1—atherosclerosis	0.000445	0.00104	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—SERPINE1—atherosclerosis	0.000423	0.000984	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NOS3—atherosclerosis	0.000404	0.00094	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CXCL8—atherosclerosis	0.000358	0.000834	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—AKT1—atherosclerosis	0.000346	0.000805	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—IL6—atherosclerosis	0.000341	0.000793	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MMP9—atherosclerosis	0.000324	0.000754	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NFKB1—atherosclerosis	0.000321	0.000746	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MAPK8—atherosclerosis	0.000315	0.000733	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—AKT1—atherosclerosis	0.000314	0.000731	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—VEGFA—atherosclerosis	0.000291	0.000677	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—STAT3—atherosclerosis	0.000288	0.00067	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MAPK3—atherosclerosis	0.000275	0.000641	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—TGFB1—atherosclerosis	0.000267	0.000621	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IL6—atherosclerosis	0.000201	0.000468	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—AKT1—atherosclerosis	0.000186	0.000432	CbGpPWpGaD
